Proposed LCD DL39927: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms — Noridian
Policy LCD-DL39927 · Oncology
Impact of LCD on billing for myeloproliferative neoplasms testing.
Code intelligence
C95.9 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C95.9.
Elevated code riskView ICD-10 detail
Signal breakdown
1 shown · 1 total in platform
Risk: Elevated
0
Critical
0%
1
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Audit documentation
Building an audit file that includes C95.9?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription